Blunt Thoracic Trauma: Definition of a Standard Operating Procedure

November 8, 2022 updated by: Raquel Gracia-Roman, Corporacion Parc Tauli

Rib fractures are the most frequent injury after blunt thoracic trauma. It is very important to choose the most appropriate interventions to prevent complications. But who will benefit most of those interventions remains a challenge.

This study analyses the correlation between chest X-Ray and CT scan. We also analyse different scores to predict respiratory failure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

553

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Sabadell, Spain
        • Hospital Universitari Parc Tauli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

We included all patients older than 18 years old admitted to our hospital due to a polytrauma that were admitted to the ICU and had a CT scan in the first 24 hours.

Description

Inclusion Criteria:

  • Polytrauma patients admitted to de ICU with a thoracic CT scan in the first 24h of arrival

Exclusion Criteria:

  • Penetrating trauma
  • Patients referred from other hospitals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Best predictor of respiratory complications
Time Frame: 01/02/2021 - 18/08/2022
Compare different items to identify the best predictor of respiratory complications: resipratory failure and pneumonia.
01/02/2021 - 18/08/2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare XRay and CT
Time Frame: 01/02/2021 - 18/08/2022
Compare findings in x-ray (read by surgeon), x-ray (read by radiologist) and CT scan
01/02/2021 - 18/08/2022
Number of fractures to predict complications
Time Frame: 01/02/2021 - 18/08/2022
Analyse if there is a number of rib fracture that can predict respiratory complications
01/02/2021 - 18/08/2022
Compare scores
Time Frame: 01/02/2021 - 18/08/2022
Compare different scores: OIS, CTS, Ribscore, Rib Fracture Score
01/02/2021 - 18/08/2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Corporacion Parc Tauli

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

November 8, 2022

First Submitted That Met QC Criteria

November 8, 2022

First Posted (Actual)

November 15, 2022

Study Record Updates

Last Update Posted (Actual)

November 15, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CGHUPTRGR01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe